Surgery – Controlled release therapeutic device or system – Implanted dynamic device or system
Reexamination Certificate
2006-05-02
2006-05-02
Woo, Julian W. (Department: 3731)
Surgery
Controlled release therapeutic device or system
Implanted dynamic device or system
C424S422000
Reexamination Certificate
active
07037304
ABSTRACT:
An implantable infection shield and system for drug delivery in vascular tissue includes a relatively non-biodegradable porous linked fibrous biomaterial which controls and directs cell growth and angiogenesis from adjacent vascular tissue into the implant. Infection shield embodiments stimulate cell growth and angiogenesis from adjacent vascular tissue which effectively blocks passage of pathogenic microorganisms along percutaneously implanted objects. In embodiments for drug delivery, a reservoir of the same biomaterial may contain either (1) a cell culture system enclosed within a porous sealable interior chamber or (2) a biodegradable matrix in which one or more drugs are dispersed. After implantation of a reservoir of the first embodiment in an organism, cultured cells obtain food and oxygen via diffusion in tissue fluid through the porous walls of the interior chamber, while metabolic products, including drugs, diffuse away from the cell culture in an analogous manner. In a reservoir of the second embodiment, a biodegradable matrix substantially fills the pores (voids), and progressive dissolution of the matrix releases one or more drugs into surrounding tissue fluid. Reservoirs of either embodiment comprise a plurality of voids of a predetermined size effective for stimulating angiogenesis from the surrounding vascular tissue into at least a portion of the reservoir. The reservoir thus acts to couple a source: of drugs to the circulatory system of the organism.
REFERENCES:
patent: 4044404 (1977-08-01), Martin et al.
patent: 4104426 (1978-08-01), Gonzalez et al.
patent: 4148962 (1979-04-01), Frosch et al.
patent: 5024671 (1991-06-01), Tu et al.
patent: 5201728 (1993-04-01), Giampapa
patent: 5629186 (1997-05-01), Yasukawa et al.
patent: 5681572 (1997-10-01), Seare, Jr.
patent: 5770417 (1998-06-01), Vacanti et al.
patent: 5964745 (1999-10-01), Lyles et al.
patent: 6031148 (2000-02-01), Hayes et al.
patent: 9110470 (1991-07-01), None
“New Challenges in Biomaterials,” Peppas et al., Science, vol. 263, Mar. 25, 1994, pp. 1715-1720.
“Tissue Engineering,” Langer et al., Science, vol. 260, pp. 920-926, May 14, 1993.
“Tissue Engineering Using Cells and Synthetic Polymers,” Mooney et al., Transportation Reviews, vol. 7, No. 3 (Jul.), 1993; pp. 153-162, Jul. 1993.
“Stabilized Polyglycolic acid fibre-based tubes for tissue engineering,” Mooney et al., Biomaterials, vol. 17, No. 2, pp. 115-124, 1996.
“Transport characterization of membranes for immunoisolation,” Dionne et al., Biomaterials, vol. 17, No. 3, pp. 257-266, 1996.
“Characterization of the formation of interfacially photopolymerized thin hydrogels in contact with arterial tissue,” Lyman et al., Biomaterials, vol. 17, No. 3, pp. 359-364, 1996.
“Biointeractive polymers and tissue engineered blood vessels,” Greisler et al., Biomaterials, vol. 17, No. 3, pp. 329-336, 1996.
“Kinetics of bone cell organization and mineralization on materials with patterned surface chemistry,”, Healy et al., Biomaterials, vol. 17, No. 2, pp. 195-208, 1996.
“Conditions which promote mineralization at the bone-implant interface: a model in vitro study,” Dee et al., Biomaterials, vol. 17, No. 2, pp. 209-215, 1996.
“Role of material surfaces in regulating bone and cartilage cell response,” Boyan et al., Biomaterials, vol. 17, No. 2, pp. 137-146, 1996.
“Bone-Grafting Materials in Implant Dentistry,” Misch et al., Implant Dentistry, vol. 2, No. 3, pp. 158-167, No Date.
“Anorganic Bovine Bone and Ceramic Analogs of Bone Mineral as Implants to Facilitate Bone Regeneration,” Myron Spector, PhD, Clinics In Plastic Surgery, vol. 21, No. 3, pp. 437-444, Jul. 1994.
“Bioactive Factors and Biosynthetic Materials in Bone Grafting,” Hollinger et al., Clinics in Plastic Surgery, vol. 21, No. 3, pp. 415-418, Jul. 1994.
“Tissue-Engineered Morphogenesis of Cartilage and Bone by Means of Cell Transportation Using Synthetic Biodegradable Polymer Matrices,” Vacanti et al., Clinics in Plastic Surgery, vol. 21, No. 3, pp. 445-462, Jul. 1994.
“Biomaterials in orthopaedic surgery: effects of different hydroxyapatites and demineralized bone matrix on proliferation rate and bone matrix synthesis by human osteoblasts,” Zambonin et al., Biomaterials, vol. 16, No. 5, pp. 397-402, 1995.
“Bone and Cartilage Reconstruction with Tissue Engineering Approaches,” Vacanti et al., Otolaryngologic Clinics of North America, vol. 27, No. 1, pp. 263-276, Feb. 1994.
“Osteogenesis in muscle with composite graft of hydroxyapatite and autogenous calvarial periosteum: a preliminary report,”Kurashina et al., Biomaterials , vol. 16, No. 2, pp. 119-123, 1995.
“Effect of Bioactive Glass Templates on Osteoblast Proliferation and In Vitro Synthesis of Bone-Like Tissue,” Ducheyne et al., Journal of Cellular Biochemistry 56:162-167 (1994).
“Biotechnology and Bone Graft Substitutes,” Kenley et al., Pharmaceutical Research, vol. 10, No. 10, 1993, pp. 1393-1401, 1993.
“Implantation of sepiolite-collagen complexes in surgically created rat calvaria defects,” Herrera et al., Biomaterials 1995, vol. 16, No. 8, pp. 625-631.
“Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats,” Marden et al., Journal of Biomedical Materials Research, vol. 28, 1127-1138 (1994).
“Facial Bone Healing and Bone Grafts,” Paul N. Manson, MD, Clinics in Plastic Surgery, vol. 21, No. 3, Jul. 1994, pp. 331-348, Jul. 1994.
“Bone Grafts and Bone Induction Substitutes,” Habal et al., Clinics in Plastic Surgery, vol. 21, No. 4, Oct. 1994, pp. 525-542.
“The Effect of Osteogenin (a Bone Morphogenetic Protein) on the Formation of Bone Orthopic Segmental Defects in Rats,” Stevenson et al., The Journal of bone and Joint Surgery, vol. 76-A, No. 11, Nov. 1994, pp. 1676-1687.
“Histomorphometric Analysis of the Repair of a Segmental Diaphyseal with Ceramic and Titanium Fibermetal Implants: Effects of Bone Marrow,” Wolff et al., Journal of Orthopaedic Research, vol. 12, No. 3, 1994, pp. 439-446, No Date.
“Symbiosis of Biotechnology and Biomaterials: Applications in Tissue Engineering of Bone and Cartilage,”A.H. Reddi, Jounal of Cellular Biochemistry, 56: 192-195 (1994).
“Bioactive material template for in vitro synthesis of bone,” El-Ghannam et al., Journal of Biomedical Materials Research, vol. 29, 359-370, 1995.
“Effect of basic fibroblast growth factor on cartilage regeneration in chondrocyte-seeded collagen sponge scaffold,” Fujisato et al., Biomaterials 1996, vol. 17, No. 2, pp. 155-162.
“Use of porous polyurethanes for meniscal reconstruction and meniscal protheses,” deGroot et al., Biomaterials 1996, vol. 17, No. 2, pp. 163-173.
“Healing of chondral and osteochondral defects in a canine model: the role of cultured chrondrocytes in regeneration of articular cartilage,” Shortkroff et al., Biomaterials 1996, vol. 17, No. 2, pp. 147-154, 1996.
“Bone Formation by Osteobalst-Like Cells in a Three-Dimensional Cell Culture,” Casser-Bette et al., Calcif Tissue Int (1990), 46:46-56.
“Attachment and proliferation of osteoblasts and fibroblasts on biomaterials for orthopaedic use,” Hunter et al., Biomaterials 1995, vol. 16, No. 4, pp. 287-295.
“The Culture of Human Osteoblasts upon Bone Graft Substitutes,” Begley et al., Bone, 14, 661-666, (1993).
“Development of a Bioartificial Liver Using Isolated Hepatocytes,” Vivek Dixit, Artificial Organs, Vol. 18, No. 5, 1994, pp. 371-384.
“Hepatic Tissue Engineering,” Yarmush et al., Annals of New York Academy of Sciences, pp. 238-252, No Date.
“Entrapment of Hepatocyte Spheroids in a Hollow Fiber Bioreactor as a Potential Bioartificial Liver,” Wu
Halff Glenn A.
Lyles Mark B.
Mallow William A.
McLaughlin Charles A.
Baker & Botts L.L.P.
Materials Evolution and Development USA Inc.
Woo Julian W.
LandOfFree
Implantable system for cell growth control does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Implantable system for cell growth control, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Implantable system for cell growth control will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3634364